Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BLTE Belite Bio, Inc.

盘后交易 12-23 18:32:23 EST

62.82

-1.30

-2.03%

盘后62.82

+0.000.00%

16:00 EST

最高64.52	最低61.99	成交量2.19万
今开63.97	昨收64.12	日振幅3.95%
总市值19.40亿	流通市值8.13亿	总股本3,088万
成交额138.47万	换手率0.17%	流通股本1,294万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BLTE","market":"US","secType":"STK","nameCN":"Belite Bio, Inc.","latestPrice":62.82,"timestamp":1734987599999,"preClose":64.12,"halted":0,"volume":21854,"hourTrading":{"tag":"盘后","latestPrice":62.82,"preClose":62.82,"latestTime":"16:00 EST","volume":285,"amount":17903.7,"timestamp":1734987601764},"delay":0,"floatShares":12940132,"shares":30879332,"eps":-1.110113,"marketStatus":"盘后交易","marketStatusCode":4,"change":-1.3,"latestTime":"12-23 18:32:23 EST","open":63.97,"high":64.52,"low":61.99,"amount":1384669.374438,"amplitude":0.039457,"askPrice":72.66,"askSize":100,"bidPrice":62,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.110113,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735002000000},"adr":0,"listingDate":1651204800000,"adjPreClose":64.12,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":65.99,"preClose":64.12,"latestTime":"08:45 EST","volume":27,"amount":1710.720108,"timestamp":1734961518649},"postHourTrading":{"tag":"盘后","latestPrice":62.82,"preClose":62.82,"latestTime":"16:00 EST","volume":285,"amount":17903.7,"timestamp":1734987601764},"volumeRatio":0.474112},"requestUrl":"/m/hq/s/BLTE","defaultTab":"news","newsList":[{"id":"2490771247","title":"Belite Bio Inc盘中异动 早盘大幅下挫5.07%报70.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490771247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490771247?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:38","pubTimestamp":1733758717,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时38分，Belite Bio Inc股票出现波动，股价急速跳水5.07%。截至发稿，该股报70.60美元/股，成交量2.332万股，换手率0.08%，振幅4.98%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为1.11%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233837984ac81d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209233837984ac81d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2489393112","title":"Belite Bio Inc盘中异动 早盘股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489393112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489393112?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:31","pubTimestamp":1733495506,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时31分，Belite Bio Inc股票出现波动，股价急速上涨6.08%。截至发稿，该股报68.97美元/股，成交量1.0744万股，换手率0.03%，振幅2.11%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.29%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223146a1d96ee7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223146a1d96ee7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2489468329","title":"Belite Bio Inc盘中异动 大幅拉升5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468329?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:34","pubTimestamp":1733409296,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时34分，Belite Bio Inc股票出现波动，股价急速上涨5.99%。截至发稿，该股报71.00美元/股，成交量2.8379万股，换手率0.09%，振幅1.72%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.09%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522345798e59e2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522345798e59e2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2489110962","title":"Belite Bio Inc盘中异动 急速上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489110962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489110962?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:53","pubTimestamp":1733334801,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时53分，Belite Bio Inc股票出现波动，股价快速拉升5.42%。截至发稿，该股报68.52美元/股，成交量1.7022万股，换手率0.06%，振幅5.72%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.40%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501532198e5656c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120501532198e5656c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2487560595","title":"Belite Bio Inc盘中异动 大幅下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487560595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487560595?lang=zh_cn&edition=full","pubTime":"2024-11-30 01:35","pubTimestamp":1732901753,"startTime":"0","endTime":"0","summary":"北京时间2024年11月30日01时35分，Belite Bio Inc股票出现异动，股价大幅下跌5.10%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.32%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130013553a25fcab5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241130013553a25fcab5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2486789938","title":"Belite Bio Inc盘中异动 早盘股价大涨5.26%报67.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486789938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486789938?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:45","pubTimestamp":1732718702,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时45分，Belite Bio Inc股票出现波动，股价急速拉升5.26%。截至发稿，该股报67.39美元/股，成交量3.2228万股，换手率0.10%，振幅7.59%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.15%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722450298e44eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112722450298e44eff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2486200904","title":"Belite Bio Inc盘中异动 早盘大幅下挫5.02%报71.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486200904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486200904?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:34","pubTimestamp":1732631677,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时34分，Belite Bio Inc股票出现波动，股价大幅下跌5.02%。截至发稿，该股报71.56美元/股，成交量1.2211万股，换手率0.04%，振幅2.52%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.23%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622343798e44a7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112622343798e44a7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2486058669","title":"Belite Bio Inc盘中异动 股价大跌5.95%报75.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486058669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486058669?lang=zh_cn&edition=full","pubTime":"2024-11-26 01:36","pubTimestamp":1732556185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日01时36分，Belite Bio Inc股票出现波动，股价急速下跌5.95%。截至发稿，该股报75.46美元/股，成交量5.1265万股，换手率0.17%，振幅5.01%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为1.65%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126013626a254de76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126013626a254de76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2485397218","title":"Belite Bio Inc盘中异动 下午盘快速下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485397218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485397218?lang=zh_cn&edition=full","pubTime":"2024-11-23 03:04","pubTimestamp":1732302260,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日03时04分，Belite Bio Inc股票出现异动，股价大幅下跌5.15%。截至发稿，该股报78.20美元/股，成交量4.1102万股，换手率0.13%，振幅4.12%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.56%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123030421abd7ff2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123030421abd7ff2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2483082300","title":"美国研究综述-AMN 医疗保健服务公司、Chart Industries 公司、家得宝公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2483082300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483082300?lang=zh_cn&edition=full","pubTime":"2024-11-13 19:30","pubTimestamp":1731497406,"startTime":"0","endTime":"0","summary":"    路透11月13日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 AMN 医疗保健服务公司、Chart Industries 公司和家得宝公司。* 908 Devices Inc   ：Leerink Partners将目标价从12美元下调至4美元             * 908 Devices Inc   ：Leerink Partners 将其目标价从 \"跑赢大盘 \"下调至 \"跑输大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOX","HD","ACLX","CLF","EWTX","LU0256863902.USD","LU2133065610.SGD","CHRW","APA","CCCS","BLTE","CHGG","ATLC","SATS","CSX","AESI","AMN","LU0128525689.USD","LU2106854487.HKD","LU2249611893.SGD","HCSG","CHH","COGT","BK4534","DAY","MASS","GTLS","AISP","DOCS","BMY","COTY","LU2065731478.USD","BHVN","COLD","ABBV","IRON","ARCH","CAVA","CRNX","ALIT","FDX","ALB","DCOM","BK4566","BK4567","BBIO","AXSM","BK4505","BCAX","BLFS"],"gpt_icon":0},{"id":"2481093982","title":"Belite Bio Inc盘中异动 大幅上涨5.02%报73.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481093982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481093982?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:45","pubTimestamp":1730907931,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时45分，Belite Bio Inc股票出现波动，股价大幅上涨5.02%。截至发稿，该股报73.62美元/股，成交量4.5641万股，换手率0.15%，振幅4.42%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.64%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106234531aba6dd07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106234531aba6dd07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2480873845","title":"Belite Bio Inc盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480873845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480873845?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:04","pubTimestamp":1730732641,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时04分，Belite Bio Inc股票出现波动，股价急速跳水5.12%。截至发稿，该股报66.32美元/股，成交量1.8587万股，换手率0.06%，振幅3.07%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.11%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230401a215583e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104230401a215583e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":1},{"id":"2480050560","title":"Belite Bio Inc盘中异动 下午盘股价大涨5.04%报63.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480050560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480050560?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:27","pubTimestamp":1730399274,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时27分，Belite Bio Inc股票出现波动，股价快速上涨5.04%。截至发稿，该股报63.60美元/股，成交量6.9646万股，换手率0.23%，振幅9.60%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为3.47%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101022754ab8cdd5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101022754ab8cdd5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2477037550","title":"Belite Bio Inc盘中异动 下午盘急速拉升5.04%报62.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477037550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477037550?lang=zh_cn&edition=full","pubTime":"2024-10-24 02:40","pubTimestamp":1729708847,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日02时40分，Belite Bio Inc股票出现异动，股价大幅拉升5.04%。截至发稿，该股报62.97美元/股，成交量7.5825万股，换手率0.25%，振幅4.92%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为1.61%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102402404798e3e0f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102402404798e3e0f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2474288771","title":"Belite Bio Inc盘中异动 临近收盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474288771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474288771?lang=zh_cn&edition=full","pubTime":"2024-10-09 03:41","pubTimestamp":1728416470,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日03时41分，Belite Bio Inc股票出现波动，股价快速上涨5.21%。截至发稿，该股报53.55美元/股，成交量8.2179万股，换手率0.27%，振幅4.60%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.33%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009034110ab68868b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009034110ab68868b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2470595837","title":"Belite Bio Inc盘中异动 临近午盘快速下挫5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470595837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470595837?lang=zh_cn&edition=full","pubTime":"2024-09-26 23:38","pubTimestamp":1727365084,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日23时38分，Belite Bio Inc股票出现波动，股价大幅跳水5.96%。截至发稿，该股报43.70美元/股，成交量2.6015万股，换手率0.08%，振幅5.10%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为0.45%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262338049719cdc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262338049719cdc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4139","KTTA","BK4007"],"gpt_icon":0},{"id":"2464236480","title":"Belite Bio 宣布委任医学博士Hendrik P. N. Scholl 为首席医疗总监","url":"https://stock-news.laohu8.com/highlight/detail?id=2464236480","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464236480?lang=zh_cn&edition=full","pubTime":"2024-09-04 08:16","pubTimestamp":1725408960,"startTime":"0","endTime":"0","summary":"今天该公司宣布，其董事会已委任医学博士 Hendrik P. N. Scholl 为首席医疗总监，即时生效。目前Hendrik Scholl博士拥有匈牙利布达佩斯塞梅尔维斯大学的荣誉博士学位，并担任奥地利维也纳医学大学的客座教授。Hendrik Scholl 毕业于德国图宾根大学医学院，取得文学硕士学位及医学博士学位。关于 Belite Bio Belite Bio 是一家临床阶段生物制药和药物开发公司，致力于针对尚无有效治疗方法的视网膜退化病变开发新型疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/04/2940166/0/zh-hant/Belite-Bio-%E5%AE%A3%E4%BD%88%E5%A7%94%E4%BB%BB%E9%86%AB%E5%AD%B8%E5%8D%9A%E5%A3%ABHendrik-P-N-Scholl-%E7%82%BA%E9%A6%96%E5%B8%AD%E9%86%AB%E7%99%82%E7%B8%BD%E7%9B%A3.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0719512351.SGD","LU0823434740.USD","LU0198837287.USD","LU0889565833.HKD","BK4529","BK4007","LU1880398554.USD","BK4573","LU0109392836.USD","LU1316542783.SGD","LU1852331112.SGD","BLTE","LU0823421333.USD","LU0823421416.USD","BK4554","LU1989764664.SGD","IE00B5949003.HKD","LU0056508442.USD","LU1064131342.USD","LU2458330169.SGD","BK4532","BK4566","IE0004445239.USD","LU2360106780.USD","BK4534","LU2098885051.SGD","LU1242518857.USD","IE00BMPRXR70.SGD","LU0823434583.USD","BK4575","LU1303367103.USD","LU0979878070.USD","LU2264538146.SGD","LU0082616367.USD","LU0127658192.USD","LU1923623000.USD","BK4588","LU1988902786.USD","LU2250418816.HKD","LU0642271901.SGD","LU1803068979.SGD","IE00BMPRXN33.USD","LU1951200564.SGD","IE0009356076.USD","LU0081259029.USD","BK4141","BK4512","LU2458330243.SGD","LU1951198990.SGD"],"gpt_icon":1},{"id":"2458329722","title":"Belite Bio Inc盘中异动 快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458329722","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458329722?lang=zh_cn&edition=full","pubTime":"2024-08-09 03:50","pubTimestamp":1723146650,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日03时50分，Belite Bio Inc股票出现波动，股价大幅上涨5.03%。截至发稿，该股报49.10美元/股，成交量1.1041万股，换手率0.04%，振幅4.86%。Belite Bio Inc股票所在的生物技术行业中，整体涨幅为3.64%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809035050968253d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809035050968253d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2457977813","title":"Belite Bio Inc盘中异动 股价大跌5.42%报45.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457977813","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457977813?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864724,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Belite Bio Inc股票出现异动，股价快速下挫5.42%。截至发稿，该股报45.05美元/股，成交量1132股，换手率0.00%，振幅0.00%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为1.36%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213205af95f9fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213205af95f9fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2445176386","title":"Belite Bio Inc盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445176386","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445176386?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:56","pubTimestamp":1718978214,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时56分，Belite Bio Inc股票出现波动，股价快速下挫5.44%。截至发稿，该股报46.26美元/股，成交量1.8156万股，换手率0.06%，振幅3.80%。Belite Bio Inc股票所在的生物技术行业中，整体跌幅为0.60%。Belite Bio Inc公司简介：Belite Bio Inc是一家临床阶段的生物制药药物开发公司，专注于针对涉及视网膜变性的不可治疗眼病的新疗法，如萎缩性年龄相关性黄斑变性和常染色体隐性Stargardt病或STGD1，这两种疾病都将逐渐导致永久性失明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621215654941f022b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621215654941f022b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLTE","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://investors.belitebio.com","stockEarnings":[{"period":"1week","weight":0.0286},{"period":"1month","weight":-0.2231},{"period":"3month","weight":0.3237},{"period":"6month","weight":0.3221},{"period":"1year","weight":0.4313},{"period":"ytd","weight":0.4015}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Belite Bio, Inc于2018年3月27日在开曼群岛注册成立。该公司是一家临床阶段的生物制药及药物开发公司，专注于针对目前无法治疗的眼部疾病的新疗法，这些疾病涉及有重大未满足医疗需求的视网膜变性，例如（i）萎缩性年龄相关性黄斑变性（AMD），通常称为地理萎缩（GA），或晚期干性AMD，和（ii）常染色体隐性遗传Stargardt病1型，或STGD1，这两种疾病都会导致进行性视力丧失，导致永久性失明。该公司的药物研发管道还包括一种小分子口服复方药物，用于治疗代谢性疾病，如非酒精性脂肪肝、非酒精性脂肪性肝炎、NASH、2型糖尿病、T2D和痛风。","exchange":"NASDAQ","name":"Belite Bio, Inc.","nameEN":"Belite Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Belite Bio, Inc.(BLTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Belite Bio, Inc.,BLTE,Belite Bio, Inc.股票,Belite Bio, Inc.股票老虎,Belite Bio, Inc.股票老虎国际,Belite Bio, Inc.行情,Belite Bio, Inc.股票行情,Belite Bio, Inc.股价,Belite Bio, Inc.股市,Belite Bio, Inc.股票价格,Belite Bio, Inc.股票交易,Belite Bio, Inc.股票购买,Belite Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Belite Bio, Inc.(BLTE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Belite Bio, Inc.(BLTE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}